| PERIOD ENDING | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | | Total Revenue | 26,524 | 26,950 | 25,159 | 29,732 | | Cost of Revenue | 18,691 | 18,848 | 17,788 | 20,858 | | | Gross Profit | 7,833 | 8,102 | 7,371 | 8,874 | | | Operating Expenses | | Research Development | 377 | 381 | 391 | 524 | | Selling General and Administrative | 8,568 | 8,714 | 8,451 | 8,614 | | Non Recurring | 8,423 | 4,543 | 405 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,535) | (5,536) | (1,876) | (264) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 19 | 5 | 16 | 14 | | Earnings Before Interest And Taxes | (9,516) | (5,531) | (1,860) | (250) | | Interest Expense | 468 | 510 | 486 | 554 | | Income Before Tax | (9,984) | (6,041) | (2,346) | (804) | | Income Tax Expense | (430) | 2,180 | (464) | 50 | | Minority Interest |
-
| 200 | 276 | 39 | | | | Net Income From Continuing Ops | (9,554) | (8,021) | (1,606) | (815) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,554) | (8,021) | (1,606) | (815) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,554) | ($8,021) | ($1,606) | ($815) |
|
0.46% Nasdaq 
Income Statement
